European Radiology

, Volume 22, Issue 9, pp 1963–1971 | Cite as

Magnetic resonance colonography in severe attacks of ulcerative colitis

  • C. Savoye-Collet
  • J. B. Roset
  • E. Koning
  • C. Charpentier
  • S. Hommel
  • E. Lerebours
  • J. N. Dacher
  • G. Savoye
Gastrointestinal

Abstract

Objectives

To evaluate the ability of MR colonography (MRC) to detect lesions in severe attacks of ulcerative colitis (UC) and to assess its concordance with rectosigmoidoscopy.

Methods

Eighteen patients underwent MRC and rectosigmoidoscopy. MRC consisted of a water-filled colonic procedure followed by T1/T2w images. Image quality was recorded. Inflammatory lesions and the existence of signs of severity were analysed. We calculated MR accuracy in the diagnosis of inflammatory lesions, as well as per segment and per patient concordance depending on the presence or absence of severe lesions.

Results

The MR image quality of the 108 segments was satisfactory. Endoscopy was used to study 36 segments (rectum and sigmoid). MRC had a positive predictive value of 100% and a sensitivity of 64% in the diagnosis of inflammatory lesions. Concordance for the diagnosis of severe lesions was excellent for the rectum (k = 0.85) and good for the sigmoid (k = 0.64). MRC diagnosed signs of severity in all patients affected at endoscopy. MRC also disclosed signs of severity located higher in the colon in four patients with nonsevere lesions at rectosigmoidoscopy.

Conclusions

MRC can accurately diagnose inflammatory lesions in severe attacks of UC and significantly correlates with rectosigmoidoscopy in the diagnosis of severe lesions.

Key Points

Magnetic Resonance Colonography (MRC) is increasingly used to investigate the large bowel.

MRC seems accurate in diagnosing inflammatory lesions in severe attacks of UC.

MRC findings significantly correlate with rectosigmoidoscopy findings for severe lesions.

Unlike rectosigmoidoscopy, MRC can identify severe lesions throughout the colon.

Keywords

Magnetic resonance imaging MR Colonography Ulcerative colitis Inflammatory bowel diseases 

Notes

Acknowledgements

The authors are grateful to Nikki Sabourin, Rouen University Hospital, for editing the manuscript.

References

  1. 1.
    Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785–1794PubMedCrossRefGoogle Scholar
  2. 2.
    Carbonnel F, Lavergne A, Lémann M, Bitoun A, Valleur P, Hautefeuille P, Galian A, Modigliani R, Rambaud JC (1994) Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 39:1550–1557PubMedCrossRefGoogle Scholar
  3. 3.
    Luboldt W, Bauerfeind P, Steiner P, Fried M, Krestin GP, Debatin JF (1997) Preliminary assessment of three-dimensional magnetic resonance imaging for various colonic disorders. Lancet 349:1288–1291PubMedCrossRefGoogle Scholar
  4. 4.
    Savoye-Collet C, Thoumas D, Savoye G, Ducrotte P, Dacher JN (2002) Colonic transit time and MR colonography. AJR Am J Roentgenol 179:435–436PubMedGoogle Scholar
  5. 5.
    Luboldt W, Steiner P, Bauerfeind P, Pelkonene P, Debatin JF (1998) Detection of mass lesions with MR colonography: preliminary report. Radiology 207:59–65PubMedGoogle Scholar
  6. 6.
    Lauenstein TC, Debatin JF (2001) Magnetic resonance colonography for colorectal screening. Semin Ultrasound CT MRI 22:443–453CrossRefGoogle Scholar
  7. 7.
    Lauenstein TC, Goehde SC, Ruehm SG, Holtmann G, Debatin JF (2002) MR colonography with barium-based fecal tagging: initial clinical experience. Radiology 223:248–254PubMedCrossRefGoogle Scholar
  8. 8.
    Rimola J, Rodríguez S, García Bosch O, Ordás I, Ayala E, Aceituno M, Pellisé M, Ayuso C, Ricart E, Donoso L, Panés J (2009) Magnetic resonance for assessment of disease activity and severity in Crohn disease. Gut 58:1113–1120PubMedCrossRefGoogle Scholar
  9. 9.
    Rimola J, Ordas I, Rodriguez S, Garcia-Bosch O, Aceituno M, Llach J, Ayuso C, Ricart E, Panes J (2011) Magnetic resonance imaging for evaluation of Crohn's disease. Validation parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17:1759–1768PubMedCrossRefGoogle Scholar
  10. 10.
    Oussalah A, Laurent V, Bruot O, Bressenot A, Bigard MA, Régent D, Peyrin-Biroulet L (2010) Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59:1056–1065PubMedCrossRefGoogle Scholar
  11. 11.
    Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845PubMedCrossRefGoogle Scholar
  12. 12.
    Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317:1625–1629PubMedCrossRefGoogle Scholar
  13. 13.
    Maccioni F, Colaiacomo MC, Parlanti S (2005) Ulcerative colitis: value of MR imaging. Abdom Imaging 30:584–592PubMedCrossRefGoogle Scholar
  14. 14.
    Langhorst J, Kühle CA, Ajaj W, Nüfer M, Barkhausen J, Michalsen A, Dobos GJ, Lauenstein TC (2007) MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm Bowel Dis 13:1001–1008PubMedCrossRefGoogle Scholar
  15. 15.
    Lauenstein TC (2006) MR colonography: current status. Eur Radiol 16:1519–1526PubMedCrossRefGoogle Scholar
  16. 16.
    Ajaj W, Goyen M (2007) MR imaging of the colon: "technique, indications, results and limitations". Eur J Radiol 61:415–423PubMedCrossRefGoogle Scholar
  17. 17.
    Kinner S, Lauenstein TC (2007) MR colonography. Radiol Clin N Am 45:377–387PubMedCrossRefGoogle Scholar
  18. 18.
    Luboldt W, Morrin MM (2002) MR colonography: status and perspective. Abdom Imaging 27:400–409PubMedCrossRefGoogle Scholar
  19. 19.
    Ajaj WM, Lauenstein TC, Pelster G, Gerken G, Ruehm SG, Debatin JF, Goehde SC (2005) Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 54:257–263PubMedCrossRefGoogle Scholar
  20. 20.
    Schreyer AG, Rath HC, Kikinis R, Völk M, Schölmerich J, Feuerbach S, Rogler G, Seitz J, Herfarth H (2005) Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut 54:250–256PubMedCrossRefGoogle Scholar
  21. 21.
    Savoye-Collet C, Dacher JN (2003) MR colonography. J Radiol 84:1733–1738PubMedGoogle Scholar
  22. 22.
    Schreyer AG, Scheibl K, Heiss P, Feuerbach S, Seitz J, Herfarth H (2006) MR colonography in inflammatory bowel diseases. Abdom Imaging 31:302–307PubMedCrossRefGoogle Scholar
  23. 23.
    Florie J, Birnie E, Van Gelder RE, Jensch S, Haberkorn B, Bartelsman JF, Van der Sluys VA, Snel P, Van der Hulst VP, Bonsel GJ, Bossuyt PM, Stoker J (2007) MR colonography with limited bowel preparation: patient acceptance compared with that of full-preparation colonoscopy. Radiology 245:150–159PubMedCrossRefGoogle Scholar
  24. 24.
    Ambrosini R, Barchiesi A, Di Mizio V, Di Terlizzi M, Leo L, Filippone A, Canalis L, Fossaceca R, Carriero A (2007) Inflammatory chronic disease of the colon: how to image. Eur J Radiol 61:442–448PubMedCrossRefGoogle Scholar
  25. 25.
    Horsthuis K, Stokkers PC, Stoker J (2008) Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities. Abdom Imaging 33:407–416PubMedCrossRefGoogle Scholar
  26. 26.
    Maccioni F, Bruni A, Viscido A, Colaiacomo MC, Cocco A, Montesani C, Caprilli R, Marini M (2006) MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238:517–530PubMedCrossRefGoogle Scholar
  27. 27.
    Madsen SM, Thomsen HS, Munkholm P, Schlichting P, Davidsen B (1997) Magnetic resonance imaging of Crohn disease: early recognition of treatment response and relapse. Abdom Imaging 22:164–166PubMedCrossRefGoogle Scholar
  28. 28.
    Schreyer AG, Gölder S, Scheibl K, Völk M, Lenhart M, Timmer A, Schölmerich J, Feuerbach S, Rogler G, Herfarth H, Seitz J (2005) Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: first clinical experience. Inflamm Bowel Dis 11:388–394PubMedCrossRefGoogle Scholar
  29. 29.
    Gore RM, Balthazar EJ, Ghahremani GG, Miller FH (1996) CT features of ulcerative colitis and Crohn's disease. AJR Am J Roentgenol 167:3–15PubMedGoogle Scholar
  30. 30.
    Koh DM, Miao Y, Chinn RJ, Amin Z, Zeegen R, Westaby D, Healy JC (2001) MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 177:1325–1332PubMedGoogle Scholar
  31. 31.
    Low RN, Sebrechts CP, Politoske DA, Bennett MT, Flores S, Snyder RJ, Pressman JH (2002) Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 222:652–660PubMedCrossRefGoogle Scholar
  32. 32.
    Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Bloom S, Cohen R, Windsor A, Obichere A, Hansmann A, Novelli M, Halligan S, Taylor SA (2009) Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252:712–720PubMedCrossRefGoogle Scholar
  33. 33.
    Horsthuis K, Bipat S, Stokkers PC, Stoker J (2009) Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur Radiol 19:1450–1460PubMedCrossRefGoogle Scholar
  34. 34.
    Röttgen R, Herzog H, Lopez-Häninnen E, Felix R (2006) Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn's disease. Clin Imaging 30:27–31PubMedCrossRefGoogle Scholar
  35. 35.
    D'Arienzo A, Scaglione G, Vicinanza G, Manguso F, Bennato R, Belfiore G, Imbriaco M, Mazzacca G (2000) Magnetic resonance imaging with ferumoxil, a negative superparamagnetic oral contrast agent, in the evaluation of ulcerative colitis. Am J Gastroenterol 95:720–724PubMedCrossRefGoogle Scholar
  36. 36.
    Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M (2000) Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Pediatr Int 42:285–288PubMedCrossRefGoogle Scholar
  37. 37.
    Carbonnel F (2004) Treatment of severe ulcerative colitis. Gastroenterol Clin Biol 28:215–217PubMedCrossRefGoogle Scholar
  38. 38.
    Bruel JM, Gallix B, Achard C, Pierredon MA, Molina E (2003) Multidetector CT and MRI in diseases of the gastrointestinal tract. J Radiol 84:499–513PubMedGoogle Scholar
  39. 39.
    Achiam MP, Logager VB, Chabanova E, Eegholm B, Thomsen HS, Rosenberg J (2009) Diagnostic accuracy of MR colonography with fecal tagging. Abdom Imaging 34:483–490PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2012

Authors and Affiliations

  • C. Savoye-Collet
    • 1
  • J. B. Roset
    • 1
  • E. Koning
    • 1
  • C. Charpentier
    • 2
  • S. Hommel
    • 2
  • E. Lerebours
    • 2
  • J. N. Dacher
    • 1
  • G. Savoye
    • 2
  1. 1.Radiology Department – QUANTIF - LITIS EA 4108Rouen University Hospital Charles NicolleRouenFrance
  2. 2.Gastroenterology Department - ADEN U 1073Rouen University Hospital Charles NicolleRouenFrance

Personalised recommendations